TrademarkDir
CYBREXA THERAPEUTICS
LIVE

Serial Number

87390727

Owner

Cybrexa, Inc.

Attorney

Patricia A. Olosky

First Use Date

Jan 1, 2018

Filing Date

Mar 29, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CYBREXA THERAPEUTICS Trademark

Serial Number: 87390727 • Registration: 6080446

CYBREXA THERAPEUTICS is a trademark filed by Cybrexa, Inc. on March 29, 2017. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Cybrexa, Inc. (5 trademarks)

New Haven, CT 06511

Entity Type: 03

Trademark Details

Filing Date

March 29, 2017

Registration Date

June 16, 2020

First Use Anywhere

January 1, 2018

First Use in Commerce

January 1, 2018

Published for Opposition

July 25, 2017

Goods & Services

Pharmaceutical drug development services, namely, development of small molecule drugs for use in humans

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 28, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 28, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 28, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 13, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 16, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 12, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 11, 2020 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2020 CRFA
ASSIGNED TO LIE
May 11, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 21, 2020 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 19, 2020 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 18, 2020 SUPC
SOU EXTENSION 5 GRANTED
Mar 18, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 18, 2020 AITU
USE AMENDMENT FILED
Mar 10, 2020 IUAF
SOU EXTENSION 5 FILED
Mar 10, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 10, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Mar 10, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2019 EXRA
SOU EXTENSION 4 GRANTED
Sep 3, 2019 EX4G
SOU EXTENSION 4 FILED
Sep 3, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 3, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2019 EXRA
SOU EXTENSION 3 GRANTED
Feb 19, 2019 EX3G
SOU EXTENSION 3 FILED
Feb 19, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 19, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2018 EXRA
SOU EXTENSION 2 GRANTED
Sep 11, 2018 EX2G
SOU EXTENSION 2 FILED
Sep 11, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 11, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2018 EXRA
SOU EXTENSION 1 GRANTED
Mar 13, 2018 EX1G
SOU EXTENSION 1 FILED
Mar 13, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 13, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 19, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 16, 2017 PREV
ASSIGNED TO LIE
Jun 7, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 28, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 28, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 28, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 28, 2017 CNEA
ASSIGNED TO EXAMINER
Apr 21, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2017 NWOS
NEW APPLICATION ENTERED
Apr 1, 2017 NWAP

Related Trademarks

More from this Owner

ALPHALEX

ALPHALEX

ALPHALEX

ALPHALEX

ALPHALEX

ALPHALEX

CYBREXA THERAPEUTICS logo

CYBREXA THERAPEUTICS

CYBREXA THERAPEUTICS logo

CYBREXA THERAPEUTICS

CYBREXA THERAPEUTICS logo

CYBREXA THERAPEUTICS